A4GNT
A4GNTgeneA4GNT modulates glycosylation of lipoproteins and immune receptors, influencing oxidative modification and inflammatory responses in atherogenesis.
Pathway placement
Cascade stepLipid retention & oxidation
Confidencemedium
RationaleAlpha-1,4-N-acetylgalactosaminyltransferase; glycosylation enzyme affecting lipoprotein structure and immune recognition.
Also acts inVascular inflammation
Druggability
DruggableYes
Known drugs / candidates0
Small-molecule tractableNo
Antibody tractableYes
EnsemblENSG00000118017
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Whole blood — gene is not a circulating analyte; measure protein product or genotype
Collection tube
K2-EDTA whole blood (lavender-top)
Method / principle
SNP genotyping / sequencing; or immunoassay of encoded protein
Reagent / substrate
Allele-specific primers/probes (TaqMan) or NGS panel; or antibody for protein
Platform
qPCR / NGS / array
Turnaround · availability
Send-out · Genotyping widely available; protein assay variable
Literature evidence(1)
- Exploring Potential Drug Targets in Multiple Cardiovascular Diseases: A Study Based on Proteome-Wide Mendelian Randomization and Colocalization Analysis.Cardiovascular therapeutics · 2025 · PMID 40026415 · doi